S. Fritsch

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 324 citations

Medicine, Hematology, Hemostasis +12

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Peter W. Collins, Sven Björkman, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2009 · 186 citations

Medicine, Hematology, Pharmacokinetics +16

Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.

László Endrényi, S. Fritsch, Wei Yan · PubMed · 1991 · 137 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring

Sven Björkman, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2010 · 123 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies

Alexandra Loew-Baselli, Ryszard Konior, Borislava G. Pavlova et al. · Vaccine · 2006 · 75 citations

Veterinary Medicine, Immunology, Infectious Diseases +11